Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

The company initially plans to launch the generic version in Canada, India, Brazil, Turkey and other emerging markets, ...

CM Revanth Reddy said that the Centre is falsely linking the 42 per cent BC quota proposal to Muslim reservation ...

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years. Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a ...

Telangana IT and Industries Minister Duddilla Sridhar Babu today reaffirmed the state government’s commitment to making ...

Dr. Reddy's reported a 2% YoY rise in Q1 profit to ₹1,418 crore with 11% revenue growth. | One of India's leading Digital News Agency offering Breaking News round the clock. Why not read our ...

Dr Reddy's reported Rs 1,417 crore net profit in Q1 FY26, driven by new launches and price hikes; firm outlines global ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Dr. Reddy’s Laboratories ( NYSE: RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo ...

A research team led by Dr. Manjula Reddy at Hyderabad’s Centre for Cellular and Molecular Biology (CCMB) has discovered a ...